Get the Stockscreener App
371.44
0.32%
-1.21
After Hours:
371.44
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $371.44, with a volume of 1.19M.
It is down -0.32% in the last 24 hours and up +2.68% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$372.65
Open:
$368.88
24h Volume:
1.19M
Relative Volume:
0.92
Market Cap:
$72.26B
Revenue:
$325.78B
Net Income/Loss:
$1.64B
P/E Ratio:
44.68
EPS:
8.3139
Net Cash Flow:
$3.61B
1W Performance:
+1.94%
1M Performance:
+2.68%
6M Performance:
+25.85%
1Y Performance:
+45.45%
1-Day Range:
$362.64
$373.77
1-Week Range:
$362.00
$376.92
52-Week Range:
$248.59
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
371.44 | 72.49B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
MCK
Mckesson Corporation
|
995.69 | 121.38B | 397.96B | 4.55B | 9.64B | 34.77 |
|
CAH
Cardinal Health Inc
|
226.35 | 54.09B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
80.21 | 9.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.4414 | 1.12B | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-22-26 | Upgrade | Jefferies | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Is Cencora’s New Veterinary Stem Cell Cold Chain Altering The Investment Case For COR? - simplywall.st
Cencora Inc. Stock: Quiet Healthcare Giant You’re Probably Sleeping On - AD HOC NEWS
Leerink Partners Adjusts Price Target on Cencora to $447 From $410, Maintains Outperform Rating - marketscreener.com
Elo Mutual Pension Insurance Co Grows Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant With 8.50% Upside Potential - DirectorsTalk Interviews
US03073EBC84 Bond Price and Chart — SWB:US03073EBC84 - TradingView
Erste Asset Management GmbH Has $3.49 Million Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Stock Is Quietly Moving Big Pharma Money – Here’s Why It Matters for You - AD HOC NEWS
US3073EBF1 Bond Analysis — Key Metrics - TradingView
Xponance Inc. Reduces Holdings in Cencora, Inc. $COR - MarketBeat
Andra AP fonden Takes $10.06 Million Position in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by American Century Companies Inc. - MarketBeat
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Handelsbanken Fonder AB Has $106.21 Million Stake in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Close Asset Management Ltd Cuts Position in Cencora, Inc. $COR - MarketBeat
Artisan Partners Limited Partnership Sells 94,061 Shares of Cencora, Inc. $COR - MarketBeat
Cencora CEO Selling Wave Prompts Fresh Look At Risks And Valuation - simplywall.st
Westfield Capital Management Co. LP Boosts Stake in Cencora, Inc. $COR - MarketBeat
Vestmark Advisory Solutions Inc. Sells 11,238 Shares of Cencora, Inc. $COR - MarketBeat
Intech Investment Management LLC Has $17.53 Million Stock Position in Cencora, Inc. $COR - MarketBeat
TD Asset Management Inc Raises Holdings in Cencora, Inc. $COR - MarketBeat
COR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
US3073EBD6 Bond Risk Analysis - TradingView
Insider Sell: Robert Mauch Sells Shares of Cencora Inc (COR) - GuruFocus
Dakota Wealth Management Sells 1,759 Shares of Cencora, Inc. $COR - Defense World
A Look At Cencora (COR) Valuation As Shares Trade Near Recent Highs - simplywall.st
AXQ Capital LP Takes $850,000 Position in Cencora, Inc. $COR - Defense World
Trajan Wealth LLC Purchases 12,346 Shares of Cencora, Inc. $COR - MarketBeat
Lansforsakringar Fondforvaltning AB publ Purchases 3,073 Shares of Cencora, Inc. $COR - MarketBeat
NewEdge Wealth LLC Has $1.06 Million Stock Holdings in Cencora, Inc. $COR - Defense World
Bleakley Financial Group LLC Cuts Stock Position in Cencora, Inc. $COR - MarketBeat
Advisors Preferred LLC Sells 18,353 Shares of Cencora, Inc. $COR - MarketBeat
US3073EBF1 Bond Risk Analysis - TradingView
Cencora (COR) CEO Robert P. Mauch sells 1,333 shares in open market - Stock Titan
Cencora, Inc. $COR Shares Sold by CenterBook Partners LP - MarketBeat
Director share sales reported by COR (NYSE: COR) in Form 144 notice - Stock Titan
What are Wall Street analysts' target price for Cencora stock? - MSN
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
NEOS Investment Management LLC Has $5.63 Million Holdings in Cencora, Inc. $COR - MarketBeat
Public Sector Pension Investment Board Grows Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Stock Rallied 50% Last Year. Here’s the Numbers Behind Sustaining That Momentum - TIKR.com
How Cencora’s (COR) Shift to Long-Term Notes for OneOncology Has Changed Its Investment Story - simplywall.st
3 Firms Steer $3.5B Cencora, Covetrus Animal Health Merger - Law360
Cencora, Inc. (COR) Announces Merger of MWI Animal Health with C - GuruFocus
Covetrus Announces Strategic Merger with MWI Animal Health - Vet Candy
Cencora (COR) and Covetrus Announce $3.5 Billion Merger - GuruFocus
Cencora to refocus on drug distribution with $3.5 billion divestiture of animal health unit - marketscreener.com
Cencora to Receive $1.25B Cash, $2.25B Equity for MWI in $3.5B Deal; Retains 34.3% Stake - TradingView
Cencora's MWI Animal Health to Merge With Covetrus - marketscreener.com
Cencora (NYSE: COR) to merge MWI with Covetrus in $3.5B deal - Stock Titan
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):